Vicks DayQuil Severe Hot Remedy
- Product NDC
- 58933-540
- Requested package NDC
- 58933-540-01
- 11-digit product format
- 589330540
- Labeler code
- 58933
- Product ID
- 58933-540_e7045315-8822-f13c-e053-2a95a90a7c5f
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen, Dextromethorphan hydrobromide, Guaifenesin and phenylephrine hydrochloride
- Dosage form
- POWDER, FOR SOLUTION
- Route
- ORAL
- Labeler
- Procter & Gamble Manufactura S de RL de CV
- Application
- M012
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2022-07-20
- Marketing end
- 0000-00-00
- Substance
- ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
- Active strength
- 650 mg/5g; mg/5g; mg/5g; mg/5g
- Pharmacologic classes
- Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 58933-540 | 58933-540-01 | D | Discontinued by firm | 2026-11-19 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vicks Sinex Severe All in One Sinus | ACETAMINOPHEN, PHENYLEPHRINE HCL | The Procter & Gamble Manufacturing Company | 9a106398-6d9d-2146-e053-2995a90a3fdf | 2026-10-02 | Warnings | M012 |
| Vicks Sinex Severe All in One Sinus Mucus | ACETAMINOPHEN, PHENYLEPHRINE HCL, GUAIFENESIN | The Procter & Gamble Manufacturing Company | 9a106291-edda-2135-e053-2995a90a44fd | 2026-10-02 | Warnings | M012 |
| Vicks Sinex SEVERE CONGESTION | OXYMETAZOLINE HYDROCHLORIDE | Procter & Gamble Manufacturing GmbH | 4644c4ae-9607-d404-e063-6294a90aca24 | 2026-10-02 | Warnings | M012 |
| VICKS SINEX SEVERE CONGESTION ORIGINAL Ultra Fine Mist | OXYMETAZOLINE HYDROCHLORIDE | Procter & Gamble Manufacturing GmbH, | 4645336e-40d8-89e6-e063-6294a90a7655 | 2026-10-02 | Warnings | M012 |
| Vicks Sinex SEVERE CONGESTION MOISTURIZING ULTRA FINE MIST | OXYMETAZOLINE HYDROCHLORIDE | Procter & Gamble Manufacturing GmbH | 464534ee-15f8-3af8-e063-6394a90a3f18 | 2026-10-02 | Warnings | M012 |
| Vicks SINEX SEVERE CONGESTION VapoCOOL ULTRA FINE MIST | OXYMETAZOLINE HYDROCHLORIDE | Procter & Gamble Manufacturing GmbH | 464550b3-5970-aca5-e063-6294a90a5954 | 2026-10-02 | Warnings | M012 |
| Vicks Jarabe Cough Congestion | DEXTROMETHORPHAN HBR AND GUAIFENESIN | The Procter & Gamble Manufacturing Company | a0fa86d4-e53b-cbf4-e053-2995a90a1396 | 2026-10-02 | Warnings | M012 |
| Vicks DayQuil Cough DM plus Congestion | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN AND PHENYLEPHRINE HYDROCHLORIDE | The Procter & Gamble Manufacturing Company | c48359ee-6e52-841d-e053-2a95a90ae293 | 2026-10-02 | Warnings | M012 |
| NyQuil VapoCOOL SEVERE COLD and FLU plus CONGESTION | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, AND PHENYLEPHRINE HYDROCHLORIDE | The Procter & Gamble Manufacturing Company | ef6df67c-0afa-4825-e053-2995a90aced9 | 2026-10-02 | Warnings | M012 |
| DayQuil and NyQuil VapoCOOL SEVERE COLD and FLU plus CONGESTION | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | The Procter & Gamble Manufacturing Company | fbd53e5f-bc03-75b4-e053-6394a90af028 | 2026-10-02 | Warnings | M012 |
| DayQuil VapoCOOL SEVERE COLD and FLU plus CONGESTION | ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE, AND GUAIFENESIN | The Procter & Gamble Manufacturing Company | ef6e8503-d268-291b-e053-2995a90aec8f | 2026-10-02 | Warnings | M012 |
| VICKS DayQuil SEVERE NyQuil SEVERE HONEY FLAVOR COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | fd03769c-2fd6-1c22-e053-6394a90a12f6 | 2026-10-02 | Warnings | M012 |
| VICKS DayQuil SEVERE HONEY FLAVOR COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Procter & Gamble Manufacturing Company | 04c9ccda-64aa-0cd0-e063-6394a90a32bf | 2026-10-02 | Warnings | M012 |
| VICKS NyQuil SEVERE HONEY FLAVOR COLD and FLU | ACETAMINOPHEN, DEXTROMETHROPHAN, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | Procter & Gamble Manufacturing Company | 04ca1e9c-f297-cbd6-e063-6294a90a3739 | 2026-10-02 | Warnings | M012 |
| Vicks DayQuil Severe Honey Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Procter & Gamble Manufacturing Company | 1b579102-9eac-1b2f-e063-6394a90add0a | 2026-10-02 | Warnings | M012 |
| Vicks NyQuil Severe Honey Cold and Flu | ACETAMINOPHEN, DEXTROMETHROPHAN, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | Procter & Gamble Manufacturing Company | d3b2ca47-d51e-f69f-e053-2995a90a587e | 2026-10-02 | Warnings | M012 |
| VICKS DayQuil NyQuil SEVERE HONEY COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 25a092c3-a9cb-6314-e063-6294a90a5297 | 2026-10-02 | Warnings | M012 |
| Vicks DayQuil HOT REMEDY Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | Procter & Gamble Manufactura S de RL de CV | 424cf178-39cc-b37c-e063-6394a90a990b | 2026-10-02 | Warnings | M012 |
| Vicks NyQuil HOT REMEDY Cold and Flu | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | Procter & Gamble Manufactura S de RL de CV | 4535d4fe-9de7-f2c6-e063-6394a90a944a | 2026-10-02 | Warnings | M012 |
| Vicks DayQuil NyQuil HOT REMEDY Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DIPHENHYDRAMINE HCL | Procter & Gamble Manufactura S de RL de CV | 457180c9-87ea-5b52-e063-6294a90a7e9d | 2026-10-02 | Warnings | M012 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 58933-540-01 | 58933054001 | 5 g in 1 PACKET (58933-540-01) | 5 g | 2022-07-20 | 0000-00-00 | No | No | Current |